| Identification | Back Directory | [Name]
CB 80 | [CAS]
1391054-76-4 | [Synonyms]
CB 80
CB 8000-13C6
Glaucol-13C6
Oratrol-13C6
Daramide-13C6
Daranide-13C6
Antidrasi-13C6
Diclofenamid-13C6
DiclofenaMide-13C6
Dichlofenamide-13C6
[13C6]-Diclofenamide
Dichlorphenamide-13C6
Dichlorophenamide-13C6
1,3-DisulfaMyl-4,5-dichlorobenzene-13C6
4,5-Dichloro-1,3-disulfaMoylbenzene-13C6
4,5-Dichloro-M-benzenedisulfonaMide-13C6
1,3-DisulfaMoyl-4,5-dichlorobenzene-13C6
Dichlorphenamide-13C6 (Diclofenamide-13C6)
3,4-Dichloro-5-sulfaMylbenzenesulfonaMide-13C6 | [Molecular Formula]
C6H6Cl2N2O4S2 | [MDL Number]
MFCD28138396 | [MOL File]
1391054-76-4.mol | [Molecular Weight]
305.159 |
| Chemical Properties | Back Directory | [Melting point ]
>220°C (dec.) | [storage temp. ]
Refrigerator | [solubility ]
Chloroform (Slightly), DMSO (Slightly) | [form ]
Solid | [color ]
Light Brown |
| Hazard Information | Back Directory | [Uses]
Labelled Diclofenamide, a potent carbonic anhydrase inhibitor. Diclofenamide may provide a therapeutic strategy in the inhibition of the human cytosolic isoforms I and II and transmembrane tumor-assoc
iated isoenzymes IX and XII. Diclofenamide has been shown to be is effective in the prevention of episodic weakness in both hypokalemic periodic paralysis (HypoPP) and potassium-sensitive periodic par
alysis (PSPP). | [Uses]
Labelled Diclofenamide, a potent carbonic anhydrase inhibitor. Diclofenamide may provide a therapeutic strategy in the inhibition of the human cytosolic isoforms I and II and transmembrane tumor-associated isoenzymes IX and XII. Diclofenamide has been shown to be is effective in the prevention of episodic weakness in both hypokalemic periodic paralysis (HypoPP) and potassium-sensitive periodic paralysis (PSPP). | [storage]
Store at -20°C |
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
| Company Name: |
ChemeGen 中国
|
| Tel: |
18818260767 |
| Website: |
https://www.chemegen.com |
|